The cobas HPV Test is a Roche real-time PCR assay for cervical cancer screening that detects high-risk HPV genotypes.
View competitors
Roche Holding AG, a Swiss healthcare company, globally manufactures and develops pharmaceutical and diagnostic products.
Founded on October 1, 1896, by Fritz Hoffmann-La Roche, Roche Holding AG is a Swiss healthcare company headquartered in Basel. The company's core mission is to innovate healthcare solutions that meet the evolving needs of patients worldwide. Roche develops and manufactures pharmaceutical and diagnostic products, focusing on areas such as cardiovascular, infectious, autoimmune, respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system. The company serves a global market, providing essential medical products and services to healthcare providers and patients.
Notable figures associated with Roche include Severin Schwan, the Chairman, and André Hoffmann, the Vice-Chairman. Over its long history, Roche has achieved significant milestones, including pioneering advancements in personalized medicine and diagnostics. The company is publicly traded on the SIX Swiss Exchange under the symbols RO (voting) and ROG (non-voting). Roche's impact is profound, continually driving forward innovations that improve patient outcomes and setting high standards in the pharmaceutical and diagnostics industries.
Roche's most recent funding round was for $5B (USD) in August 2021.
As of Aug 4, 2021, Roche has disclosed funding of $7.8B (USD).
Acquisition by Roche announced
May 7, 2026 for $750M

Unity Biotechnology

Treeline Biosciences

Memic Innovative Surgery

PAQ Therapeutics

Inbrace

Matchpoint Therapeutics

ONL Therapeutics

Step Pharma

Skyhawk Therapeutics

CeQur

Ablative Solutions

Areteia Therapeutics

MOMA Therapeutics

LifeMine Therapeutics

Draig Therapeutics

ENYO Pharma

Exo Therapeutics

HiberCell

Cardiac Dimensions

Zhimeng Biopharma